[PHARMA] QoQ TTM Result on 30-Sep-2015 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
26-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 5.03%
YoY- 34.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 2,295,554 2,276,603 2,189,312 2,136,265 2,113,938 2,126,165 2,122,933 5.35%
PBT 97,079 100,648 112,722 126,859 126,467 126,033 125,580 -15.78%
Tax -26,952 -29,520 -28,138 -21,695 -26,277 -26,528 -31,355 -9.60%
NP 70,127 71,128 84,584 105,164 100,190 99,505 94,225 -17.88%
-
NP to SH 69,407 70,629 84,044 104,679 99,663 99,421 93,844 -18.23%
-
Tax Rate 27.76% 29.33% 24.96% 17.10% 20.78% 21.05% 24.97% -
Total Cost 2,225,427 2,205,475 2,104,728 2,031,101 2,013,748 2,026,660 2,028,708 6.37%
-
Net Worth 524,177 515,906 529,786 534,373 528,477 528,173 525,351 -0.14%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 64,750 69,935 77,704 90,625 88,011 80,234 72,463 -7.23%
Div Payout % 93.29% 99.02% 92.46% 86.57% 88.31% 80.70% 77.22% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 524,177 515,906 529,786 534,373 528,477 528,173 525,351 -0.14%
NOSH 258,981 258,859 259,064 259,027 259,057 258,908 258,794 0.04%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 3.05% 3.12% 3.86% 4.92% 4.74% 4.68% 4.44% -
ROE 13.24% 13.69% 15.86% 19.59% 18.86% 18.82% 17.86% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 886.38 879.48 845.08 824.73 816.01 821.20 820.32 5.30%
EPS 26.80 27.28 32.44 40.41 38.47 38.40 36.26 -18.26%
DPS 25.00 27.00 30.00 35.00 34.00 31.00 28.00 -7.28%
NAPS 2.024 1.993 2.045 2.063 2.04 2.04 2.03 -0.19%
Adjusted Per Share Value based on latest NOSH - 259,027
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 159.28 157.96 151.91 148.23 146.68 147.52 147.30 5.35%
EPS 4.82 4.90 5.83 7.26 6.92 6.90 6.51 -18.17%
DPS 4.49 4.85 5.39 6.29 6.11 5.57 5.03 -7.29%
NAPS 0.3637 0.358 0.3676 0.3708 0.3667 0.3665 0.3645 -0.14%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 5.50 5.76 6.36 6.50 7.13 6.00 4.58 -
P/RPS 0.62 0.65 0.75 0.79 0.87 0.73 0.56 7.02%
P/EPS 20.52 21.11 19.60 16.08 18.53 15.62 12.63 38.24%
EY 4.87 4.74 5.10 6.22 5.40 6.40 7.92 -27.71%
DY 4.55 4.69 4.72 5.38 4.77 5.17 6.11 -17.85%
P/NAPS 2.72 2.89 3.11 3.15 3.50 2.94 2.26 13.15%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 19/08/16 13/05/16 15/02/16 26/11/15 17/08/15 18/05/15 23/02/15 -
Price 5.62 5.60 6.19 6.50 5.65 6.91 5.28 -
P/RPS 0.63 0.64 0.73 0.79 0.69 0.84 0.64 -1.04%
P/EPS 20.97 20.52 19.08 16.08 14.69 17.99 14.56 27.56%
EY 4.77 4.87 5.24 6.22 6.81 5.56 6.87 -21.60%
DY 4.45 4.82 4.85 5.38 6.02 4.49 5.30 -11.00%
P/NAPS 2.78 2.81 3.03 3.15 2.77 3.39 2.60 4.56%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment